Home / Biotechnology / Metabolomi

Metabolomics Market By Product And Services (Metabolomic Instruments, Metabolomics Bioinformatics Tools And Services), By Application (Biomarker Discovery, Drug Discovery, Functional Genomics, Personalized Medicine, Toxicology Testing, Nutrigenomics), By Indication (Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors Of Metabolism) - Growth, Future Prospects And Competitive Analysis 2017 - 2025

Metabolomics is a novel, emerging and dynamic field that studies metabolites, a distinctive chemical fingerprints produced during cellular process. Thus it identifies and quantifies metabolites further with the help of analytical technologies and application of bioinformatics extract information and analyze the same. Metabolomics though currently at nascent stage, will be widely used in biopharma and biotech industry as biomarker drug development and information. Being non-invasive in nature and closely linked to phenotype, it is an ideal tool used in agricultural industries, pharmaceutical and preventive healthcare. Rise in the number of clinical trials, awareness about nutritional products, toxicological testing data, rapid growth of metabolomics data analysis software and solutions is expected to propel the growth of this market.

The report titled “Metabolomics market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall metabolomics market along with the market size and estimates for the duration 2015 to 2025. The said research study covers in-depth analysis of multiple market segments based on type of product and services, application, indication and different geographies. The product and services type segment studied for analyzing the overall global metabolomics market is majorly segmented into metabolomics instruments and metabolomics bioinformatics tools and services. Metabolomics instruments is sub-segmented into separation tools and detection tools. Separation tools include high-performance liquid chromatography, gas chromatography, ultra-performance liquid chromatography and capillary electrophoresis. Detection tools comprise mass spectrometry, nuclear magnetic resonance spectroscopy and surface-based mass analysis. Metabolomics bioinformatics tools and services category is sub-segmented into bioinformatics tools & databases, and bioinformatics services. The global metabolomics market is segmented by application type into biomarker discovery, drug discovery, toxicology testing, nutrigenomics, functional genomics, personalized medicine and others. Based on indications, this market is categorized into cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism and others.

Geographically, the global metabolomics market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Mexico
    • Brazil
    • Rest of LATAM
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • Rest of MEA

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global metabolomics market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global metabolomics market. This report concludes with company profiles section that highlights major information about the key players engaged in global metabolomics market. In-depth competitive environment analysis and historical (2015) market size data are also provided in the report.

Metabolomics Market

Based on the type of indication, the global metabolomics market is segmented as follows:

  • Cancer
  • Cardiovascular Disorders
  • Neurological Disorders
  • Inborn Errors of Metabolism
  • Others

Cancer dominates the global metabolomics market by indication segmentation. Cancer study through metabolomics helps in revealing new biomarkers for cancer which would help in future diagnosis, prognosis and therapy. Cardiovascular chronic disease is the greatest public health burden globally. Thus use of metabolomic profiling would help to identify new biomarkers and mechanisms of CVD risk. Current clinical diagnosis of neurological diseases such as Parkinson’s and Alzheimer diseases on basis of clinical criteria is unsatisfactory, so emerging metabolomics techniques help in discovering in now biomarker and biochemical pathway for improving the  future diagnosis and determination of prognosis therapy.

Metabolomics Market

For the purpose of this study, the global metabolomics market is geographically categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Metabolomics Market

North America dominates the global metabolomics market followed by Europe. The key drivers are surge in research and development funding by government and private players for metabolomics studies, rising demand for personalized medicine and toxicology testing, easy accessibility of technologically advanced products and its high adoption rate, presence of various metabolomics manufactures. Growing demand for the personalized medicine, large presence of the analytical equipment manufacturers in Europe contribute to the growth of metabolomics market. Asia Pacific has significant growth opportunity for the metabolomics market due to presence of number of pharmaceutical and biotechnology companies and its initiatives in research and development, improving health care infrastructure, emerging economies such as China, Japan, India and Singapore.

Choose License Type
Budget Buying
Executive Summary - Brief Global Market Size - Current & Forecast
Regional Market Size - North America
Country Market Size - US
Company Profile – 1
Trusted By
Published Date:  Apr 2017
Category:  Biotechnology
Report ID:   58420
Report Format:   PDF
Pages:   120
Rating:    4.5 (60)
Delivery Time: 24 Hours to 48 Hours   
Connect With Us
24/7 Research Support